approval
saveAMLODIPINE BESYLATE — FDA approval
January 26, 2026updated 5mo ago
community read0 votes
Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 5
- recallGraviti Pharmaceuticals Private Limited recall (Cls II)Jan 28, 2026
- approvalAMLODIPINE BESYLATE — FDA approvalFeb 17, 2026
- approvalTRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalDec 29, 2025
- approvalTRAMADOL HYDROCHLORIDE — FDA approvalDec 23, 2025
- approvalGLIPIZIDE — FDA approvalMar 4, 2026
🐶 often sniffed alongside
top 8- tagRecall4 co-mentions · 2 sources
- companyGraviti Pharmaceuticals Pvt Ltd2 co-mentions · 1 sources
- drugAUVELITY2 co-mentions · 1 sources
- drugFUROSEMIDE2 co-mentions · 1 sources
- drugbupropion2 co-mentions · 1 sources
- drugBUPROPION HYDROCHLORIDE2 co-mentions · 1 sources
- drugbupropion hydrochloride ER2 co-mentions · 1 sources
- drugbupropion hydrochloride MR2 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that